Why is Indrayani Biotec falling/rising?

As of 22-Aug, Indrayani Biotech Ltd's stock price is currently at 12.80, reflecting a slight increase of 0.05 or 0.39%. The stock has shown a trend reversal by gaining after four consecutive days of decline, although it remains below its moving averages across various time frames. Despite today's performance being in line with the sector, the stock has significantly underperformed with a 1-week return of -3.40% and a staggering -64.82% year-to-date. The company's weak long-term fundamentals, including a -253.18% CAGR growth in operating profits over the last five years and negative results for the last five consecutive quarters, contribute to its status as a strong sell. Additionally, a high Debt to EBITDA ratio of 7.34 times and a declining interest from institutional investors further exacerbate the stock's challenges.
Broader market context indicates that while the Sensex has gained 0.88% over the past week, Indrayani Biotech's performance has been notably poor, highlighting its consistent underperformance against the benchmark. The stock's year-to-date decline of -64.82% starkly contrasts with the Sensex's positive return of 4.05% during the same period. This disparity underscores the stock's riskiness and the negative sentiment surrounding it, particularly given the significant drop in profitability and the lack of investor confidence reflected in the decreasing institutional stake.